ESRRG and neoplasm: Given the primary role of chemotherapy resistance in SCLC treatment failure, we developed a cell-based and patient-derived chemoresistant SCLC xenograft models and used them to evaluate the efficacy of combination treatment with an ERRγ antagonist and chemotherapy for inhibiting tumor growth and metastasis.